InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,598.80
(
1.03%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.35
(
-0.16%
)
Bitcoin
63,386.34
(
0.35%
)
Post# of 37328
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

roger that

Send PM Follow Ignore
Followers 18
Posts 4053
Boards Moderated 0
Alias Born 07/08/2003

roger that

Re: None

Friday, 01/27/2017 12:07:03 PM

Friday, January 27, 2017 12:07:03 PM

Post# of 37328
Revenue increased 39.2% to $851,930 compared with the same quarter in 2015;
Revenue increased 15.8% over the third quarter 2016;
2016 revenue was $3,048,126 up 42.3% over fiscal year 2015;
Group B. Strep test revenue increased 274% to $150,570 compared with a year ago, and 38.5% quarter over quarter;
Newly launched Shiga Toxin Direct Test and Staph ID/R Blood Culture Panel revenues were $51,720 combined; and
Submitted 510(k) application for Stool Pathogens Panel to the FDA.

“paper’ll lay down and let you write whatever you want on it.”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up